Search Within

Raajit Kumar Rampal

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (67)
  2. Journal Article (58)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Adult Leukemia (127)
  2. Center for Hematologic Malignancies (127)
  3. Department of Medicine (127)
  4. Executive Committee, Center for Hematologic Malignancies (127)
  5. GSK Faculty (127)
  6. Hematologic Malignancies, Division of (127)

More Groups

People
  1. Ross Levine (86)
  2. Omar Abdel-Wahab (63)
  3. Eli Diamond (27)
  4. Martin Tallman (27)
  5. Ahmet Dogan (25)
  6. Minal Patel (24)

More People

Years
  1. 2023 (7)
  2. 2022 (5)
  3. 2021 (6)
  4. 2020 (14)
  5. 2019 (7)
  6. 2018 (16)

More Years

Publications
  1. Blood (55)
  2. Haematologica (6)
  3. Pediatric Blood and Cancer (6)
  4. Blood Advances (5)
  5. Cancer Discovery (5)
  6. Laboratory Investigation (4)

More Publications

Publishers
  1. American Society of Hematology (60)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (7)
  4. Ferrata Storti Foundation (6)
  5. Wiley Periodicals, Inc (6)
  6. Elsevier Inc. (4)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • MPN transformation is characterized by heterogeneous shifts in lineage character
    Meeting Abstract

    Dilip, D.; Menghrajani, K.; Glass, J.; Rampal, R. K.; Famulare, C.; Sirenko, M.; Levine, R. L.; Koche, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
    Journal Article

    Dunbar, A. J.; Kim, D.; Lu, M.; Farina, M.; Bowman, R. L.; Yang, J. L.; Park, Y.; Karzai, A.; Xiao, W.; Zaroogian, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Erythroid and megakaryocytic differentiation program in JAK2-mutated acute myeloid leukemia with or without antecedent myeloproliferative neoplasm
    Meeting Abstract

    Liu, Y.; Sethi, S.; Koche, R.; Gao, Q.; Dilip, D.; Glass, J. L.; Galera, P. K.; Persaud, S.; Mishra, T.; Sun, X.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Mutational profile of children with myeloproliferative neoplasms
    Meeting Abstract

    Rutherford, K.; Farnoud, N.; Krishnan, A.; Rampal, R. K.; Levine, R. L.; Kucine, N.
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save